Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
boston blog main
boston top stories
clinical trials
life sciences
national blog main
parkinson's disease
2
×
acorda therapeutics
allergan
alzheimer's disease
ampyra
apokyn
apomorphine
biotech
boston
crispr
cynthia collins
dalfampridine
deals
duopa
editas medicine
gene editing
inbrija
leber congenital amaurosis type 10
michelle robertson
mylan
national top stories
new york
new york blog main
new york top stories
paul matteis
rare diseases
san francisco blog main
stiel
sunovion pharmaceuticals
voyager therapeutics
What
treatment
2
×
abbvie
acorda
alliance
approved
biotech
cope
disease
drug
editas
editing
episodes
exits
experimental
fda
friday
gene
genetic
gets
help
late
looms
meant
medications
medicines
new
nod
pact
parkinson’s
partnership
patients
pruning
research
returning
rights
rival
stop
terminated
working
Language
unset
Current search:
treatment
×
" parkinson's disease "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms